Andreas Kluge

Andreas Kluge

Chief Executive Officer at
Therapeia GmbH & Co. Kg

Net worth: 194 M $ as of 2026-05-30

Health Technology
Consumer Services
Process Industries

Profile

Andreas Kluge founded Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002, and Telix Pharmaceuticals Ltd. in 2015, where he worked as Non-Executive Director from 2020 to 2024.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-05 20,675,000 ( 6.09% ) 194 M $ 2026-05-30

Andreas Kluge active positions

CompaniesPositionStart
Chief Executive Officer 2006-12-31
ABX-CRO advanced pharmaceutical services
Founder 2002-07-31

Former positions of Andreas Kluge

CompaniesPositionEnd
TELIX PHARMACEUTICALS LIMITED Founder 2024-10-16
Chief Executive Officer 2002-06-30
See the detail of Andreas Kluge's experience

Training of Andreas Kluge

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Process Industries

Health Technology

Health Technology

ABX-CRO advanced pharmaceutical services

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!